Impressive performance in an extraordinary year to date

Key takeaways

Venture fundraising in healthcare soared to $10.4B in the first half of 2020, nearly matching 2019’s full-year record.


Biopharma investments are up, led by large mezz deals

IPO valuations and proceeds are on record pace and post-IPO stock performance has been incredible.


Dx/Tools are on track for record investment, four IPOs boasted $1B+ market caps at mid-year

Led by many companies leveraging their technologies to aid the COVID-19 response.


HealthTech led post-IPO performance with a $2B+ IPO that then increased its stock price by over 100%

Companies focused on providing alternative care outside the hospital raised 46% of capital in this sector.